Source comparison
Can You Take Melanotan-2 Orally?: Administration Comparison
Oral capsule/tablet <1% Stomach (pepsin), small intestine (trypsin, chymotrypsin) None—below detection limit None—peptide structure destroyed before receptor binding Not viable—enzymatic degradation prevents systemic delivery Sublingual (under tongue) <5% Sali
This comparison does not assign a generated winner or score.
- Oral capsule/tablet
- <1%
- Stomach (pepsin), small intestine (trypsin, chymotrypsin)
- None—below detection limit
- None—peptide structure destroyed before receptor binding
- Not viable—enzymatic degradation prevents systemic delivery
- Sublingual (under tongue)
- <5%
- Salivary enzymes, swallowed portion undergoes gastric degradation
- Minimal—trace amounts only
- Negligible—insufficient plasma concentration to activate melanocortin receptors
- Marginally better than oral but still ineffective for melanogenesis
- Subcutaneous injection
- >90%
- Minimal—some local peptidase activity in interstitial fluid
- 60–90 minutes
- Full activation—intact peptide binds MC1R and MC4R at therapeutic concentrations
- Only proven method—delivers functional peptide to target receptors
- Intravenous injection
- ~100%
- None during administration—cleared by renal filtration and hepatic metabolism
- Immediate (within 5 minutes)
- Rapid and complete—but short-lived due to rapid clearance
- Fastest onset but impractical for repeated dosing—subcutaneous preferred
- Nasal spray
- 10–15% (highly variable)
- Nasal mucosa enzymes, drip-back into throat undergoes gastric degradation
- 20–40 minutes (inconsistent)
- Partial—some receptor activation but unreliable dose-to-effect relationship
- Emerging research route but not yet validated for Melanotan-2 specifically
- The table above makes it clear: if you take Melanotan-2 orally, you're ingesting expensive amino acids—not activating melanocortin pathways.